Improvement of Outcome for Treatment of ‘Restenosis-prone’ Vascular Lesions? Potential Impact of the Paclitaxel dose on Late Lumen Loss in Porcine Peripheral Arteries

Albrecht T, Schnorr B, Kutschera M, Waliszewski MW. Two-Year Mortality After Angioplasty of the Femoro-Popliteal Artery with Uncoated Balloons and Paclitaxel-Coated Balloons-A Pooled Analysis of Four Randomized Controlled Multicenter Trials. Cardiovasc Intervent Radiol. 2019;42(7):949–55.

PubMed  Article  Google Scholar 

Caradu C, Lakhlifi E, Colacchio EC, Midy D, Berard X, Poirier M, et al. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease. J Vasc Surg. 2019;70(3):981-95.e10.

PubMed  Article  Google Scholar 

Feng H, Chen X, Guo X, Zhang Z, Zhang Z, Liu B, et al. Comparison of efficacy and safety of drug-eluting versus uncoated balloon angioplasty for femoropopliteal arterial occlusive disease: a meta-analysis. BMC Cardiovasc Disord. 2020;20(1):395.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN PACT SFA randomized trial. Circulation. 2015;131(15):495–502.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwalder U, Beregi JP, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358(7):689–99.

CAS  PubMed  Article  Google Scholar 

Ullah W, Zghouzi M, Sattar Z, Ahmad B, Zahid S, Suleiman AM, et al. Safety and efficacy of drug-coated balloon for peripheral artery revascularization-A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2022;99(4):1319–26.

PubMed  Article  Google Scholar 

Werk M, Albrecht T, Meyer DR, Ahmed MN, Behne A, Dietz U, et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv. 2012;5(6):831–40.

CAS  PubMed  Article  Google Scholar 

Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008;118(13):1358–65.

CAS  PubMed  Article  Google Scholar 

Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular surgery (ESVS). Rev Esp Cardiol (Engl Ed). 2018;71(2):111.

Article  Google Scholar 

Schlager O, Gschwandtner ME, Willfort-Ehringer A, Wolf F, Loewe C, Koppensteiner R, et al. Drug coated balloons in the superficial femoral artery. J Cardiovasc Surg (Torino). 2018;59(1):60–9.

Google Scholar 

Granada JF, Stenoien M, Buszman PP, Tellez A, Langanki D, Kaluza GL, et al. Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing. Open Heart. 2014;1(1):e000117.

PubMed  PubMed Central  Article  Google Scholar 

Murphy GJ, Johnson TW, Chamberlain MH, Rizvi SI, Wyatt M, George SJ, et al. Short- and long-term effects of cytochalasin D, paclitaxel and rapamycin on wall thickening in experimental porcine vein grafts. Cardiovasc Res. 2007;73(3):607–17.

CAS  PubMed  Article  Google Scholar 

Speck U, Hackel A, Schellenberger E, Kamann S, Lochel M, Clever YP, et al. Drug distribution and basic pharmacology of paclitaxel/resveratrol-coated balloon catheters. Cardiovasc Intervent Radiol. 2018;41(10):1599–610.

PubMed  PubMed Central  Article  Google Scholar 

Gemeinhardt O, Schnorr B, Speck U, Scheller B. A novel paclitaxel coated balloon with increased drug transfer for treatment of complex vascular lesions. PLoS ONE. 2021;16(10):e0259106.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Jeger RV, Eccleshall S, Wan Ahmad WA, Ge J, Poerner TC, Shin ES, et al. Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group. JACC Cardiovasc Interv. 2020;13(12):1391–402.

PubMed  Article  Google Scholar 

Cassese S, Ndrepepa G, Fusaro M, Kufner S, Xhepa E, Fusaro M. Paclitaxel density and clinical efficacy of drug-coated balloon angioplasty for femoropopliteal artery disease: meta-analysis and adjusted indirect comparison of 20 randomised trials. EuroIntervention. 2019;15(6):e560–2.

PubMed  Article  Google Scholar 

Kelsch B, Scheller B, Biedermann M, Clever YP, Schaffner S, Mahnkopf D, et al. Dose response to paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model. Invest Radiol. 2011;46(4):255–63.

CAS  PubMed  Article  Google Scholar 

Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004;110(7):810–4.

CAS  PubMed  Article  Google Scholar 

Giacoppo D, Cassese S, Harada Y, Colleran R, Michel J, Fusaro M, et al. Drug-coated balloon versus plain balloon angioplasty for the treatment of femoropopliteal artery disease: an updated systematic review and meta-analysis of randomized clinical trials. JACC Cardiovasc Interv. 2016;9(16):1731–42.

PubMed  Article  Google Scholar 

Katsanos K, Spiliopoulos S, Paraskevopoulos I, Diamantopoulos A, Karnabatidis D. Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated balloon angioplasty in the femoropopliteal arteries: role of paclitaxel dose and bioavailability. J Endovasc Ther. 2016;23(2):356–70.

PubMed  Article  Google Scholar 

Laird JA, Schneider PA, Jaff MR, Brodmann M, Zeller T, Metzger DC, et al. Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions. Circ Cardiovasc Interv. 2019;12(6):e007702.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Lookstein RA, Haruguchi H, Ouriel K, Weinberg I, Lei L, Cihlar S, et al. Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas. N Engl J Med. 2020;383(8):733–42.

CAS  PubMed  Article  Google Scholar 

Tepe G, Schroeder H, Albrecht T, Reimer P, Diehm N, Baeriswyl JL, et al. Paclitaxel-coated balloon vs uncoated balloon angioplasty for treatment of in-stent restenosis in the superficial femoral and popliteal arteries: The COPA CABANA trial. J Endovasc Ther. 2020;27(2):276–86.

PubMed  Article  Google Scholar 

Bettink S, Lochel M, Peters D, Haider W, Speck U, Scheller B. Efficacy and safety of a magnesium stearate paclitaxel coated balloon catheter in the porcine coronary model. Int J Cardiol. 2021;331:46–56.

PubMed  Article  Google Scholar 

Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol. 1992;19(2):267–74.

CAS  PubMed  Article  Google Scholar 

Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol. 1998;31(1):224–30.

CAS  PubMed  Article  Google Scholar 

Steiner S, Schmidt A, Zeller T, Tepe G, Thieme M, Maiwald L, et al. COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions. Eur Heart J. 2020;41(27):2541–52.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Trerotola SO, Saad TF, Roy-Chaudhury P. The Lutonix AV randomized trial of paclitaxel-coated balloons in arteriovenous fistula stenosis: 2year results and subgroup analysis. J Vasc Interv Radiol. 2020;31(1):1-14.e5.

PubMed  Article  Google Scholar 

Vazquez-Padron RI, Duque JC, Tabbara M, Salman LH, Martinez L. Intimal hyperplasia and arteriovenous fistula failure: looking beyond size differences. Kidney360. 2021;2(8):1360–72.

PubMed  PubMed Central  Article  Google Scholar 

Abadal JM, Vazquez E, Morales M, Toro A, Quintana M, Araujo M. Pharmacokinetic evaluation of two paclitaxel-coated balloons with different drug load in a short-term porcine study. Cardiovasc Interve Radiol. 2016;39(8):1152–8.

CAS  Article  Google Scholar 

Torii S, Jinnouchi H, Sakamoto A, Romero ME, Kolodgie FD, Virmani R, et al. Comparison of biologic effect and particulate embolization after femoral artery treatment with three drug-coated balloons in healthy swine model. J Vasc Interv Radiol. 2019;30(1):103–9.

PubMed  Article  Google Scholar 

Yazdani SK, Pacheco E, Nakano M, Otsuka F, Naisbitt S, Kolodgie FD, et al. Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model. Catheter Cardiovasc Interv. 2014;83(1):132–40.

PubMed  Article  Google Scholar 

Clever YP, Peters D, Calisse J, Bettink S, Berg MC, Sperling C, et al. Novel sirolimus-coated balloon catheter: in vivo evaluation in a porcine coronary model. Circ Cardiovasc Interv. 2016;9(4):e003543.

CAS  PubMed  Article  Google Scholar 

Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7(24):e011245.

PubMed  PubMed Central  Article  Google Scholar 

Bohme T, Noory E, Beschorner U, Jacques B, Burgelin K, Macharzina R, et al. Evaluation of mortality following paclitaxel drug-coated balloon angioplasty of femoropopliteal lesions in the real world. JACC Cardiovasc Interv. 2020;13(17):2052–61.

PubMed  Article  Google Scholar 

Donas KP, Sohr A, Pitoulias GA, Alfonso F, Torsello G. Long-Term mortality of matched patients with intermittent claudication treated by high-dose paclitaxel-coated balloon versus plain balloon angioplasty: a real-world study. Cardiovasc Interve Radiol. 2020;43(1):2–7.

Article  Google Scholar 

Freisinger E, Koeppe J, Gerss J, Goerlich D, Malyar NM, Marschall U, et al. Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis. Eur Heart J. 2020;41(38):3732–9.

PubMed  Article 

留言 (0)

沒有登入
gif